Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus

Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients

(2012) Sayed H. Naderi et al.   AMERICAN JOURNAL OF MEDICINE

Efficacy of Post-Operative Clopidogrel Treatment in Patients Revascularized With Coronary Artery Bypass Grafting After Myocardial Infarction

(2011) Rikke Sørensen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Current Use of Aspirin and Antithrombotic Agents in the United States Among Outpatients With Atherothrombotic Disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)

(2010) Christopher P. Cannon et al.   AMERICAN JOURNAL OF CARDIOLOGY

Diabetic Gastroparesis

(2009) Jing Ma et al.   DRUGS

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

(2009) Kornelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Hospital Variation in Use of Secondary Preventive Medicine After Discharge for First Acute Myocardial Infarction During 1995–2004

(2009) Søren Rasmussen et al.   MEDICAL CARE

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

(2007) Elliott M. Antman et al.   CIRCULATION